Data is not available at this time.
China Reform Health Management and Services Group operates as a specialized medical insurance management service provider within China's expansive healthcare sector. The company generates revenue primarily through administering medical insurance programs, serving 177 medical insurance schemes across 25 provinces. This positions it as a significant intermediary in China's healthcare financing system, facilitating the management and processing of insurance claims between patients, healthcare providers, and insurers. Its operations are deeply integrated into the regional public health infrastructure, leveraging its nationwide network to offer scalable administrative solutions. The company's pivot from its former identity as SeaRainbow Holding Corp. in 2018 signifies a strategic focus on the growing demand for efficient health management services driven by government healthcare reforms and an aging population. This niche focus allows it to capitalize on the complexity of China's fragmented insurance market, acting as a vital service partner rather than a direct insurer or care provider. Its market position is defined by its extensive geographic coverage and specialized expertise, which are critical for navigating the regulatory and operational intricacies of managing multi-province insurance programs.
For the fiscal year, the company reported revenue of approximately CNY 357 million. However, it recorded a net loss of CNY 10.4 million, resulting in a negative diluted EPS of CNY -0.0106. Operational efficiency appears challenged, as indicated by negative operating cash flow of CNY -82.5 million, which was significantly impacted by capital expenditures of CNY -37.6 million. This suggests that current cash generation from core business activities is insufficient to cover investing activities.
The company's earnings power is currently constrained, as evidenced by the net loss. The negative operating cash flow further highlights difficulties in converting revenue into cash. Capital expenditures are substantial relative to the company's scale, indicating ongoing investments in its service infrastructure, though the immediate return on this invested capital is not yet reflected in positive profitability metrics.
The balance sheet shows a cash and equivalents position of CNY 451.8 million, which provides a liquidity buffer against the reported losses and negative cash flow. Total debt stands at CNY 261.7 million. The relationship between its cash holdings and debt levels offers some short-term stability, but the persistent cash burn from operations warrants close monitoring of its long-term financial health and liquidity management.
The provided data does not include historical figures to assess revenue or profit growth trends. The company maintains a conservative capital return policy, with a dividend per share of zero, indicating that all capital is being retained to fund operations and potential growth initiatives rather than distributed to shareholders.
The market capitalization is approximately CNY 9.83 billion. A beta of 0.656 suggests the stock has historically been less volatile than the broader market. The valuation appears to be factoring in future growth potential or strategic value within China's healthcare system, rather than being supported by current earnings, given the present lack of profitability.
The company's primary strategic advantage lies in its established, extensive network across 25 provinces, which creates significant barriers to entry for competitors. Its deep integration into China's public health insurance infrastructure positions it to benefit from ongoing healthcare reforms and increasing insurance coverage. The outlook depends on its ability to leverage this platform to achieve sustainable profitability and positive cash flow from its core administrative services.
Company Description and Financial Data from Provider
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |